XPA impacts formation but not proteasome-sensitive repair of DNA-protein cross-links induced by chromate. 2010

Alma Zecevic, and Elizabeth Hagan, and Mindy Reynolds, and Graham Poage, and Tatiana Johnston, and Anatoly Zhitkovich
Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912, USA.

DNA-protein cross-links (DPCs) are caused by a large number of human carcinogens and anti-cancer drugs. However, cellular processes involved in decreasing a burden of these genotoxic lesions remain poorly understood. Here, we examined the impact of nucleotide excision repair (NER), which is a principal repair pathway for bulky DNA adducts, and the main cellular reducers on removal of chromium(VI)-induced DPC. We found that standard and ascorbate-restored cultures of isogenic XPA-null (NER deficient) and XPA-complemented human fibroblasts had very similar repair of Cr-DPC (60-65% average DPC removal after 24 h). However, XPA absence caused depletion of G1 and accumulation of G2 cells at low Cr(VI) doses, suggesting that Cr-DPC were not a significant cause of cell cycle perturbations. Interestingly, although pro-oxidant metabolism of Cr(VI) in glutathione-depleted cells generated significantly fewer DPC, they were repair resistant irrespective of the NER status of cells. Inhibition of proteasome activity by MG132 abolished DPC repair in both XPA-null and XPA-complemented cells. XPA loss caused two to three times higher initial DPC formation, demonstrating the importance of NER in removal of the precursor lesions. Our results indicate that human NER is not involved in removal of Cr-DPC containing non-histone proteins but it acts as a defence mechanism against these large lesions by preventing their formation. Therefore, individual differences in NER activity are expected to alter sensitivity but not persistence of DPC as a biomarker of hexavalent Cr.

UI MeSH Term Description Entries
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D002840 Chromates Salts of chromic acid containing the CrO(2-)4 radical. Chromate
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D046988 Proteasome Endopeptidase Complex A large multisubunit complex that plays an important role in the degradation of most of the cytosolic and nuclear proteins in eukaryotic cells. It contains a 700-kDa catalytic sub-complex and two 700-kDa regulatory sub-complexes. The complex digests ubiquitinated proteins and protein activated via ornithine decarboxylase antizyme. 20S Proteasome,Ingensin,Macropain,Macroxyproteinase,Multicatalytic Endopeptidase Complex,Multicatalytic Proteinase,Prosome,Proteasome,Complex, Multicatalytic Endopeptidase,Complex, Proteasome Endopeptidase,Endopeptidase Complex, Multicatalytic,Endopeptidase Complex, Proteasome,Proteasome, 20S,Proteinase, Multicatalytic
D051760 Xeroderma Pigmentosum Group A Protein A ZINC FINGER MOTIF protein that recognizes and interacts with damaged DNA. It is a DNA-binding protein that plays an essential role in NUCLEOTIDE EXCISION REPAIR. Mutations in this protein are associated with the most severe form of XERODERMA PIGMENTOSUM. XPA Nucleotide Excision Repair Protein,XPA Repair Protein,Xeroderma Pigmentosum Group A Complementing Protein,Xeroderma Pigmentosum-A Protein,Xeroderma Pigmentosum A Protein

Related Publications

Alma Zecevic, and Elizabeth Hagan, and Mindy Reynolds, and Graham Poage, and Tatiana Johnston, and Anatoly Zhitkovich
July 1981, Biulleten' eksperimental'noi biologii i meditsiny,
Alma Zecevic, and Elizabeth Hagan, and Mindy Reynolds, and Graham Poage, and Tatiana Johnston, and Anatoly Zhitkovich
January 2020, Frontiers in cell and developmental biology,
Alma Zecevic, and Elizabeth Hagan, and Mindy Reynolds, and Graham Poage, and Tatiana Johnston, and Anatoly Zhitkovich
May 2017, International journal of molecular sciences,
Alma Zecevic, and Elizabeth Hagan, and Mindy Reynolds, and Graham Poage, and Tatiana Johnston, and Anatoly Zhitkovich
February 2006, Chemical reviews,
Alma Zecevic, and Elizabeth Hagan, and Mindy Reynolds, and Graham Poage, and Tatiana Johnston, and Anatoly Zhitkovich
July 1984, Carcinogenesis,
Alma Zecevic, and Elizabeth Hagan, and Mindy Reynolds, and Graham Poage, and Tatiana Johnston, and Anatoly Zhitkovich
July 2006, Cell cycle (Georgetown, Tex.),
Alma Zecevic, and Elizabeth Hagan, and Mindy Reynolds, and Graham Poage, and Tatiana Johnston, and Anatoly Zhitkovich
November 1995, Carcinogenesis,
Alma Zecevic, and Elizabeth Hagan, and Mindy Reynolds, and Graham Poage, and Tatiana Johnston, and Anatoly Zhitkovich
January 2021, The Journal of biological chemistry,
Alma Zecevic, and Elizabeth Hagan, and Mindy Reynolds, and Graham Poage, and Tatiana Johnston, and Anatoly Zhitkovich
March 2020, International journal of molecular sciences,
Alma Zecevic, and Elizabeth Hagan, and Mindy Reynolds, and Graham Poage, and Tatiana Johnston, and Anatoly Zhitkovich
December 1973, The Yale journal of biology and medicine,
Copied contents to your clipboard!